REGINA UBALDI-ROSEN: Open Payments
NPI 1073550968 · ASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,500 in 126 payments from 28 companies in 2025. Trend: 2023 $2,531 · 2024 $2,506 · 2025 $2,500
Food & beverage: $2,500
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $318 |
| PFIZER INC. | 18 | $268 |
| ABBVIE INC. | 14 | $243 |
| AstraZeneca Pharmaceuticals LP | 10 | $221 |
| Axsome Therapeutics, Inc. | 7 | $163 |
| SANOFI-AVENTIS U.S. LLC | 5 | $108 |
| HARMONY BIOSCIENCES LLC | 3 | $103 |
| Kowa Pharmaceuticals America, Inc. | 6 | $96 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| Exact Sciences Corporation | 4 | $91 |
Products named: Auvelity, AIRSUPRA, Wegovy, PREVNAR 20, ELIQUIS, TZIELD, WAKIX, Ozempic.
Industry payments across PA — which companies pay providers there.
